Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine

European Journal of Pharmacology

Volumn 512, Issue 1, 2005, Pages 37-42

  Wu, Chi Chen ^a,b   Chen, Julia Yi Ru ^a,b   Tao, Pao Luh ^c   Chen, Yi Ann ^d   Yeh, Geng Chang ^a,b,d  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Morphine withdrawal syndrome; Naloxone; Neonatal rat; Serotonin reuptake transporter inhibitor

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; MORPHINE; NALOXONE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME; YAWNING;

EID: 16244366790     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.02.002     Document Type: Article

References (34)

1. H. Akaoka, and G. Aston-Jones Indirect serotonergic agonists attenuate neuronal opiate withdrawal Neuroscience 54 1993 561 565
2. T. Archer, G. Jonsson, B.G. Minor, and C. Post Noradrenergic-serotonergic interactions and nociception in the rat Eur. J. Pharmacol. 120 1986 295 307
3. A. Argiolas, and M.R. Melis The neuropharmacology of yawning Eur. J. Pharmacol. 343 1998 1 16
4. W.K. Bickel, M.L. Stitzer, I.A. Liebson, and G.E. Bigelow Acute physical dependence in man: effects of naloxone after brief morphine exposure J. Pharmacol. Exp. Ther. 244 1988 126 132
5. M.C. Boadle-Biber, J.N. Johannessen, N. Narasimhachari, and T.H. Phan Activation of cortical tryptophan hydroxylase by acute morphine treatment: blockade by 6-hydroxydopamine Eur. J. Pharmacol. 139 1987 193 204
6. D.A. Brase Roles of serotonin and gamma-aminobutyric acid in opioid effects Adv. Biochem. Psychopharmacol. 20 1979 409 428
7. J.C. Chen, P.L. Tao, J.Y. Li, C.H. Wong, and E.Y. Huang Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats Peptides 24 2003 477 481
8. A.O. el-Kadi, and S.I. Sharif The role of 5-HT in the expression of morphine withdrawal in mice Life Sci. 57 1995 511 516
9. M. Foguet, J.A. Hartikka, K. Schmuck, and H. Lubbert Long-term regulation of serotonergic activity in the rat brain via activation of protein kinase A EMBO J. 12 1993 903 910
10. H.H. Hansen, and J.D. Mikkelsen Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor Eur. J. Pharmacol. 352 1998 307 315
11. G.C. Harris, and G. Aston-Jones Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal Neuropsychopharmacology 24 2001 75 85
12. B.L. Jacobs, and E.C. Azmitia Structure and function of the brain serotonin system Physiol. Rev. 72 1992 165 229
13. J.M. Lauder, J.A. Wallace, H. Krebs, P. Petrusz, and K. McCarthy In vivo and in vitro development of serotonergic neurons Brain Res. Bull. 9 1982 605 625
14. L. Lu, W.J. Su, W. Yue, X. Ge, F. Su, G. Pei, and L. Ma Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor Life Sci. 69 2001 37 46
15. K.E. McGrath, F.J. Seidler, and T.A. Slotkin Convergent control of serotonin transporter expression by glucocorticoids and cocaine in fetal and neonatal rat brain Brain Res. Dev. Brain Res. 104 1997 209 213
16. M.J. Millan, A. Gobert, F. Lejeune, A. Newman-Tancredi, J.M. Rivet, A. Auclair, and J.L. Peglion S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine J. Pharmacol. Exp. Ther. 298 2001 565 580
17. D.L. Murphy Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems Neuropsychopharmacology 3 1990 457 471
18. C.P. O'Brien Drug application and drug abuse J.G. Hardman L.E. Limbrid P.B. Molinoff R.W. Ruddon A.G. Gilman The Goodman and Gilman's the pharmacological basis of therapeutics 1996 McGraw Hill New York 557 580
19. E.M. Ostrea Jr., C.J. Chavez, and M.E. Strauss A study of factors that influence the severity of neonatal narcotic withdrawal Addict. Dis. 2 1975 187 199
20. M.J. Owens, W.N. Morgan, S.J. Plott, and C.B. Nemeroff Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites J. Pharmacol. Exp. Ther. 283 1997 1305 1322
21. M.R. Pranzatelli Dissociation of the plasticity of 5-HT1A sites and 5-HT transporter sites Neurochem. Res. 19 1994 311 315
22. M.R. Pranzatelli, and J.M. Martens Plasticity and ontogeny of the central 5-HT transporter: effect of neonatal 5,7-dihydroxytryptamine lesions in the rat Brain Res. Dev. Brain Res. 70 1992 191 195
23. M. Rafieian-Kopaei, A.M. Gray, P.S. Spencer, and R.D. Sewell Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning Eur. J. Pharmacol. 275 1995 185 189
24. K. Ramabadran Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphine Life Sci. 33 1983 385 388
25. V.P. Singh, N.K. Jain, and S.K. Kulkarni On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor Brain Res. 915 2001 218 226
26. S. Tanganelli, T. Antonelli, M. Morari, C. Bianchi, and L. Beani Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs Neurosci. Lett. 122 1991 270 272
27. R. Tao, and S.B. Auerbach Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine J. Neurochem. 63 1994 517 524
28. R. Tao, Z. Ma, and S.B. Auerbach Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine J. Pharmacol. Exp. Ther. 286 1998 481 488
29. P.L. Tao, G.C. Yeh, C.H. Su, and Y.H. Wu Co-administration of dextromethorphan during pregnancy and throughout lactation significantly decreases the adverse effects associated with chronic morphine administration in rat offspring Life Sci. 69 2001 2439 2450
30. P.J. Tiseo, J. Cheng, G.W. Pasternak, and C.E. Inturrisi Modulation of morphine tolerance by the competitive N-methyl-d-aspartate receptor antagonist LY274614: assessment of opioid receptor changes J. Pharmacol. Exp. Ther. 268 1994 195 201
31. S. Tokuyama, H. Wakabayashi, and I.K. Ho Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome Eur. J. Pharmacol. 295 1996 123 129
32. K.A. Trujillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 1991 85 87
33. J.J. Volpe Teratogenic effects of drugs and passive addiction J.J. Volpe Neurology of the newborn 1995 W.B. Saunder Philadelphia, PA 811 850
34. G.C. Yeh, P.L. Tao, J.Y. Chen, M.C. Lai, F.S. Gao, and C.L. Hu Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine Eur. J. Pharmacol. 453 2002 197 202